Osteomalacia as a rare complication of intravenous iron supplementation

Abstract

Iron deficiency (ID) and Iron deficiency anaemia (IDA) are very common among patients with chronic heart failure, chronic kidney disease, inflammatory bowel disease and pre-menopausal and pregnant women. Both ID and IDA can be managed effectively with intravenous Iron supplementation, which has been shown to be superior to oral Iron therapy. We are presenting a patient in her third trimester of pregnancy, who was diagnosed with IDA and treated with intravenous ferric carboxymaltose. This patient developed a rare complication of osteomalacia, which presented as a diagnostic challenged leading to ongoing symptoms until the appropriate diagnosis was made.